Gordian Biotechnology
Focus: Gordian Biotechnology operates a drug screening platform focused on neurology and cardiovascular disease, positioning itself as an early-stage biotech innovator in platform-based drug discovery.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
3-1 this month
Stable — net -1 jobs in 30d
1 added, 2 removed. Backfill posture.
Should You Work at Gordian Biotechnology?
AI assessmentGordian is a speculative early-stage platform play best suited for scientists seeking discovery-stage exposure and equity upside, with meaningful execution risk.
Why Work Here
- Platform technology model offers exposure to emerging drug discovery methodologies in high-value therapeutic areas (neurology and cardiovascular)
- Early-stage positioning means potential for significant equity upside and meaningful career progression in a lean organization
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Recent News · Gordian Biotechnology(1)
Help build intelligence for Gordian Biotechnology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.